Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Zhejiang AngLiKang Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Revenue

¥1.4 B

FY, 2025

CreditSafe Score

?
Score changed on Jun 15, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CNYFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue1.2B1.4B1.3B1.4B1.5B1.6B1.5B1.4B
Cost of goods sold378.3M375.3M317.4M487.8M670.5M900.5M920.7M862.4M
Gross profit861.3M1.0B958.0M877.6M882.7M708.1M602.7M545.5M
Gross profit margin, %69.5%73.6%75.4%64.5%57.1%44.2%40.2%39.3%
Operating expense total702.0M816.0M743.3M630.4M678.0M407.2M393.4M299.5M
Depreciation and amortization39.1M38.0M41.5M77.4M62.5M129.7M88.2M76.2M
EBITDA155.3M177.4M210.2M231.3M198.7M297.6M200.8M226.2M
EBITDA margin, %12.5%13.0%16.5%17.0%12.9%18.6%13.4%16.3%
EBIT136.1M147.6M196.2M157.2M137.9M199.2M155.0M197.9M
EBIT margin, %11.0%10.8%15.4%11.6%8.9%12.4%10.3%14.3%
Interest income5.9M20.4M19.1M25.8M17.5M21.9M19.0M13.7M
Interest expense2.3M124.0K171.0K368.0K6.4M14.2M16.6M13.0M
Pre tax profit137.3M153.7M210.7M172.6M146.9M207.2M158.4M180.3M
Income tax expense15.6M27.2M29.4M31.3M15.0M24.1M6.5M23.5M
Net Income121.7M126.5M181.3M141.3M132.0M183.1M151.9M156.7M

Footer menu